Humanigen has always been different than other biotech microcaps even if the market lumps us in with companies like CYDY and RLFTF. Fortunately, government scientists/officials understand the reality and have consistently supported Humanigen. That is almost surely because Durrant and Chappell are well respected scientists who play by the rules instead of being greasy. It will pay off soon when lenz gets the EUA. It is so unbelievable that CYDY and RLFTF still have market caps higher than HGEN.